ClinConnect ClinConnect Logo
Search / Trial NCT06686732

Multimodal Rehabilitation Approach in Patients of Lateral Epicondylitis

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 12, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Tennis Elbow Manual Therapy Multimodal Treatment Hand Strength

ClinConnect Summary

This clinical trial is studying a new treatment approach for people with lateral epicondylitis, commonly known as tennis elbow. The researchers want to see if a multimodal rehabilitation program—using a combination of therapies—is more effective than traditional treatments for easing pain and improving function in the arm. They are looking for participants aged 18 to 45 who have experienced localized pain on the outer part of their elbow for at least two months and have tested positive on three specific physical tests.

Participants in the trial can expect to be part of a study that lasts eight months, where they will be randomly assigned to one of two treatment groups. They will undergo assessments before and after the treatment using tools like pain scales and strength tests to measure their progress. This trial is important because it aims to provide better evidence on how effective this new rehabilitation approach is for tennis elbow, which can help inform future treatment options. If you have had elbow pain and meet the criteria, this could be an opportunity to contribute to research that may benefit others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Point tenderness at the lateral epicondyle
  • Positive Cozen test, Mill\'s test and Maudsely's test
  • Symptoms duration of minimum 2 months
  • Consenting to participate in the study
  • Exclusion Criteria:
  • History of fracture in elbow, wrist or hand
  • History of surgery in elbow, wrist or hand region
  • Elbow conditions other than lateral epicondylitis
  • Cognitive deficits and not giving consent

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Wāh, Punjab, Pakistan

Islamabad, , Pakistan

Rawalpindi, , Pakistan

Patients applied

0 patients applied

Trial Officials

Ramsha Tariq, MS*

Principal Investigator

Riphah International University, Islamabad

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported